After opening the day flat, Indian share markets remained muted throughout the session and ended flat.

Benchmark indices ended flat as investors took note of weakness in other Asian markets and booked profits at higher levels. The pessimism also was because of concerns about a trade conflict between the United States and China.

At the closing bell, the BSE Sensex stood lower by 33 points.

Meanwhile, the NSE Nifty closed up by 10 points.

Bajaj Auto and Maruti Suzuki were among the top gainers today.

HDFC Bank and HDFC on the other hand, were among the top losers today.

Check out the NSE Nifty heatmap to get the complete list of gainers and losers.

The Gift Nifty was trading at 19,532, up by 39 points, at the time of writing.

Broader markets ended on a positive note. The BSE Midcap index and BSE SmallCap ended 0.6% higher.

Sectoral indices ended on a mixed note with stocks in the auto sector and FMCG sector witnessing most of the buying.

On the other hand, stocks from the telecom sector and banking sector witnessed selling pressure.

Shares of Maruti Suzuki and Britannia hit their 52-week highs today.

Now track the biggest movers of the stock market using stocks to watch today section. This should help you keep updated with the latest developments...

Asian stock markets ended on a negative note. The Nikkei ended lower by 0.3%, while the Hang Seng ended down by 1.6%. The Shanghai Composite ended lower by 0.7%.

The rupee is trading at 82.23 against the US$.

Gold prices for the latest contract on MCX are trading 0.4% higher at Rs 58,617 per 10 grams.

Meanwhile, silver prices for the latest contract on MCX are trading marginally lower at Rs 70,445 per kg.
 

Maruti Suzuki's Aggressive EV Plans

In news from the auto sector, Maruti Suzuki India on Wednesday reaffirmed its commitment to the electric vehicle (EV) market by announcing plans to introduce six EV models in India by the fiscal year 2030-31.

The move comes as the company aims to tap into the growing demand for EVs, where other brands like Tata Motors have made substantial headway.

Further, Maruti Suzuki launched its most expensive car Invicto at an event today. The Invicto is Maruti Suzuki's premium offering in the hybrid segment.

Apart from this, driving the EV revolution, it is developing hybrid electric vehicles (HEV) with Toyota.

Note that the electric vehicle (EV) megatrend is a once-in-a-century revolution happening right in front of us.

The revolution has taken the auto sector by storm. All segments of the sector are ripe for disruption, and India's top EV stocks are set to benefit from this shift.

L&T's order win

Moving on to news from the engineering sector, Engineering and infrastructure conglomerate Larsen & Toubro, on Wednesday, announced that its buildings and factories' fast business under the construction vertical has bagged a significant order for developing office space in Mumbai.

The company would develop a commercial office space with an approximate built-up area of 14.85 lakh square feet using composite steel construction technology.

The scope of the project involves EPC, including civil works, composite steel, facade, MEP, and External Development Activities to construct basements, ground, and 12 floors. The project is scheduled to be completed in 2026.

Last month, L&T announced that the construction vertical bagged new significant orders in India and abroad for power transmission and distribution-related activities.

Note that L&T has rewarded investors with 10 bonuses over the last 7 decades and the CAGR over the last 20 years stands at an impressive 25.6%.

L&T has been an investor's favorite stock for a long time and also a stock that makes it to the top 5 infrastructure stocks.

In line with its commitment to a sustainable future, L&T is poised to make significant strides in the green hydrogen landscape. 
 

Venus Remedies expands global presence

Moving on to news from the pharma sector, pharma major Venus Remedies on Wednesday received marketing approval from Oman, Malaysia, Bosnia, and Trinidad and Tobago for key chemotherapy drugs.

With this, it has secured 503 marketing approvals for its oncology products across 75 countries.

Venus Remedies has secured marketing approval for pemetrexed from Malaysia, one of the largest markets in the ASEAN region.

These marketing approvals will enable the company to expand our operations to new geographies and open up new avenues for advanced cancer treatment with improved outcomes for patients battling various types of cancer.

Venus Remedies has already submitted dossiers to the Malaysian Health Ministry for another nine marketing authorizations, which include pending approvals for two oncology products.

The company expects the marketing approval for docetaxel from the USD 1.4-billion pharmaceutical market in Oman to facilitate the registration process in other Gulf countries as well, considering that many of them have similar regulatory requirements and processes.

Having secured its first marketing authorization from Bosnia, the company expects this approval for gemcitabine from the Euro 334 million pharma market to facilitate the registration process in the entire Balkan region, which has a market size of Euro 7 billion.

More By This Author: